199 related articles for article (PubMed ID: 7674228)
41. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
42. Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Kameda T; Dobashi H; Miyatake N; Inoo M; Onishi I; Kurata N; Mitsunaka H; Kawakami K; Fukumoto T; Susaki K; Izumikawa M; Nakashima S; Shimada H; Takeuchi Y; Haba R; Mano S; Onishi H; Imataki O; Matsunaga T
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1302-9. PubMed ID: 24515570
[TBL] [Abstract][Full Text] [Related]
43. Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.
Shimada K; Yokosuka K; Nunokawa T; Sugii S
Clin Rheumatol; 2018 Aug; 37(8):2269-2274. PubMed ID: 29876690
[TBL] [Abstract][Full Text] [Related]
44. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
Nash P; Nicholls D
Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
[TBL] [Abstract][Full Text] [Related]
45. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis.
Hilliquin P; Renoux M; Perrot S; Puéchal X; Menkès CJ
Br J Rheumatol; 1996 May; 35(5):441-5. PubMed ID: 8646434
[TBL] [Abstract][Full Text] [Related]
46. Late-onset methotrexate-induced pneumonitis with neutrophilia in bronchoalveolar lavage fluid.
Yamakawa H; Yoshida M; Takagi M; Kuwano K
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25267808
[TBL] [Abstract][Full Text] [Related]
47. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
[TBL] [Abstract][Full Text] [Related]
48. Methotrexate-induced pneumonitis: heterogeneity of bronchoalveolar lavage and differences between cancer and rheumatoid arthritis.
D'Elia T
Inflamm Allergy Drug Targets; 2014 Feb; 13(1):25-33. PubMed ID: 24372368
[TBL] [Abstract][Full Text] [Related]
49. Successful reintroduction of methotrexate after pneumonitis in two patients with rheumatoid arthritis.
Cook NJ; Carroll GJ
Ann Rheum Dis; 1992 Feb; 51(2):272-4. PubMed ID: 1290480
[TBL] [Abstract][Full Text] [Related]
50. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
[TBL] [Abstract][Full Text] [Related]
52. Neurological and pulmonary adverse effects of subcutaneous methotrexate therapy.
Sommer WH; Ganiere V; Gachoud D; Keta A; Abou-Hajar A; Dudler J; Aujesky D
Scand J Rheumatol; 2008; 37(4):306-9. PubMed ID: 18612932
[TBL] [Abstract][Full Text] [Related]
53. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients.
Imokawa S; Colby TV; Leslie KO; Helmers RA
Eur Respir J; 2000 Feb; 15(2):373-81. PubMed ID: 10706507
[TBL] [Abstract][Full Text] [Related]
54. Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate.
Usman AR; Yunus MB
J Rheumatol; 1996 Jun; 23(6):1095-7. PubMed ID: 8782146
[TBL] [Abstract][Full Text] [Related]
55. Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis.
Flood DA; Chan CK; Pruzanski W
J Rheumatol; 1991 Aug; 18(8):1254-6. PubMed ID: 1941836
[TBL] [Abstract][Full Text] [Related]
56. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
57. Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis.
Dascalu C; Mrejen-Shakin K; Bandagi S
J Clin Rheumatol; 2010 Jun; 16(4):172-4. PubMed ID: 20511978
[TBL] [Abstract][Full Text] [Related]
58. Drug-induced pneumonitis: the role of methotrexate.
Zisman DA; McCune WJ; Tino G; Lynch JP
Sarcoidosis Vasc Diffuse Lung Dis; 2001 Oct; 18(3):243-52. PubMed ID: 11587095
[TBL] [Abstract][Full Text] [Related]
59. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
60. [Rheumatoid arthritis and malignancy].
Kameda T; Dobashi H
Nihon Rinsho; 2016 Jun; 74(6):1017-21. PubMed ID: 27311195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
